Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naxozol vs Celecoxib in Osteoarthritis
NCT02355236Phase 4Unknown
- Sponsor
- Severance Hospital
- Start
- Feb 2015
- Primary completion
- Dec 2015
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of NAXOZOL in osteoarthritis (OA) (2 arms), sponsored by Severance Hospital. Primary endpoint: Leeds Dyspepsia Questionnaire Change at 12 weeks. Status: unknown.
02
Drugs
NAXOZOL
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02355236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355236.